SHIRE BIOPHARMACEUTICALS HOLDINGS
Company Information
- Company Number
- 05492592
- Registered Address
- 1 Kingdom Street, London, United Kingdom, W2 6BD
- Status
- Dissolved
- Employee Count
- 0
- Turnover
- Coming Soon
- EBITDA
- -£556,114,000
Additional Details
- Website
- https://shire.com
- Company Type
- Private unlimited company
- Incorporated On
- 27 June 2005
- Nature of Business
- 70100 - Activities of head offices
- Industries
- Professional Services
- Region
- London
Company Review
Trend Analysis
The trend for SHIRE BIOPHARMACEUTICALS HOLDINGS in terms of average time to pay invoices has been decreasing over the past three periods. In the first period (Jan 2018 - Jun 2018), the average time to pay was not available, but in the second period (Jul 2018 - Dec 2018), it decreased by 10.5%. In the most recent period (Jan 2019 - Jun 2019), it decreased by an additional 5.3%. This shows a positive trend towards paying invoices in a timely manner.
Volatility Analysis
The volatility of SHIRE BIOPHARMACEUTICALS HOLDINGS in terms of average time to pay invoices has been relatively stable over the past three periods. In the first period, the data was not available. In the second period, the average time to pay increased by 0.8%. In the most recent period, it decreased by 1.2%. This shows a slight fluctuation, but overall, the company has been consistent in their payment practices.
Summary Analysis
In terms of percentage of invoices paid within 30 days, SHIRE BIOPHARMACEUTICALS HOLDINGS has shown improvement over the past three periods. In the first period, the data was not available. In the second period, 71.3% of invoices were paid within 30 days, and in the most recent period, 74.5% were paid within 30 days. This shows a positive trend towards early payment.
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jul 2018 - 31 Dec 2018 | 28 Jan 2019 | |||||
| 01 Jan 2018 - 30 Jun 2018 | 27 Jul 2018 |
Payment Time Trends
Payment Distribution Trends
Company Summary
SHIRE BIOPHARMACEUTICALS HOLDINGS is a leading biopharmaceutical company based in the United Kingdom. The company focuses on developing innovative treatments for rare diseases and other specialty conditions.
As part of their sustainability program, SHIRE BIOPHARMACEUTICALS HOLDINGS is committed to reducing their environmental impact and promoting responsible business practices. They have implemented various initiatives such as reducing waste, conserving energy, and promoting sustainable sourcing.
The company's products and services include treatments for rare diseases such as hemophilia, hereditary angioedema, and lysosomal storage disorders. They also offer therapies for other specialty conditions such as ADHD, gastrointestinal diseases, and ophthalmic disorders.
Some key people at SHIRE BIOPHARMACEUTICALS HOLDINGS include Dr. Flemming Ornskov, the CEO, and Dr. Howard Mayer, the Chief Medical Officer. Both have extensive experience in the biopharmaceutical industry and have played crucial roles in the company's success.
For more information on SHIRE BIOPHARMACEUTICALS HOLDINGS and their products and services, you can visit their website at www.shire.com. Their registered office address is in Hampshire, United Kingdom, and they also have global offices in various locations around the world.
